Skip to main content

McKesson Corporation guidance

  • MCK · NYSE
  • Distribution
  • Health Care Distributors
  • S&P 500
$1094.60−0.94%Close 17 Nov 2026 · Market value $126.3B

In its results release of 4 Nov 2026 (Q2 FY2027), McKesson Corporation gave 1 forecast in figures, among them EPS (adjusted) of $45.60 to $46.40 for FY2027.

Read from the company's earnings releases and outlook updates of the last two years. Each forecast is shown with the sentence or table row it was read from; what a release does not state in figures is not shown.

Latest guidance given with Q2 FY2027 results, 4 Nov 2026

MeasurePeriodGuidanceAs stated
EPS · Adjusted · RaisedFY2027$45.60 to $46.40Raised Adjusted Earnings per Diluted Share guidance range to $45.60 to $46.40, from the previous range of $44.20 to $45.00.

Source: the company's earnings release.

Guidance against results above 1 · within 0 · below 0

The last range given before each period closed, how it moved between releases, and the figure then filed. A measure the company defines itself, or one not comparable with the filed figure, has no verdict.

MeasurePeriodLast guidanceRevisionsDeliveredResult
EPS · AdjustedFY2027$45.60 to $46.40Raised twice—To come
RevenueFY2025$307.1BRaised twice, lowered once$403.4BAbove the range

MCK in the terminal

Guidance said on earnings calls, every revision charted, and guidance set against the analysts' consensus.